Aleglitazar
Aleglitazar (R1439) is a dual agonist of PPARα and PPARγ with IC50 values of 38 nM and 19 nM, respectively. It has been investigated in preclinical research for type 2 diabetes, including studies on glycemic control and lipid metabolism in vitro and in animal models.
Product Specifications
CAS Number
475479-34-6
Product Name Alternative
R1439, R-1439, PPARα, PPARγ, R 1439, RO0728804, RO-0728804, RO 0728804, Aleglitazar
Field of Research
Metabolism Research, Molecular Biology
Purity
99.03% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.57 mM) ; DMSO:45 mg/mL (102.85 mM)
Smiles
C ([C@@H] (C (O) =O) OC) C1=C2C (=C (OCCC=3N=C (OC3C) C4=CC=CC=C4) C=C1) C=CS2
Molecular Formula
C24H23NO5S
Molecular Weight
437.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15158053 1 Vial
Lentiviral human CDH13 shRNA (UAS) - Lentiviral human CDH13 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
302632-PE 100 µL
PABPC5 (Polyadenylate-Binding Protein 5, PABP-5, Poly (A) -Binding Protein 5, PABPC5, PABP5) (PE) discontinued
Sign In for Pricing
View Details